Brief Research Report

Published on 19 Jul 2022

The Role of Clonal Evolution on Progression, Blood Parameters, and Response to Therapy in Multiple Myeloma

in Hematologic Malignancies

Sarah Sandmann
Katharina Karsch
Peter Bartel
Rita Exeler
Tobias J. Brix
Elias K. Mai
Julian Varghese
Georg Lenz
Cyrus Khandanpour

Frontiers in Oncology

doi 10.3389/fonc.2022.919278

2,380 views
2 citations

Original Research

Published on 18 Jul 2022

Survival Risk Scores for Real-Life Relapsed/Refractory Multiple Myeloma Patients Receiving Elotuzumab or Carfilzomib In Combination With Lenalidomide and Dexamethasone as Salvage Therapy: Analysis of 919 Cases Outside Clinical Trials

in Hematologic Malignancies

Fortunato Morabito
Elena Zamagni
Concetta Conticello
Vincenzo Pavone
Salvatore Palmieri
Sara Bringhen
Monica Galli
Silvia Mangiacavalli
Daniele Derudas
Elena Rossi

Frontiers in Oncology

doi 10.3389/fonc.2022.890376

3,024 views
2 citations

Review

Published on 18 Jul 2022

MRD in Venetoclax-Based Treatment for AML: Does it Really Matter?

in Hematologic Malignancies

Massimo Bernardi
Felicetto Ferrara
Matteo Giovanni Carrabba
Sara Mastaglio
Francesca Lorentino
Luca Vago
Fabio Ciceri

Frontiers in Oncology

doi 10.3389/fonc.2022.890871

7,054 views
3 citations

Case Report

Published on 18 Jul 2022

Allogeneic haematopoietic stem cell transplantation with decitabine-containing preconditioning regimen in TP53-mutant myelodysplastic syndromes: A case study

in Hematologic Malignancies

Yuxin Wang
Yao Sun
Jing Xie
Jiangwei Hu
Na Liu
Jianlin Chen
Botao Li
Sanchun Lan
Jingwen Niu
Lei Wang

Frontiers in Oncology

doi 10.3389/fonc.2022.928324

2,327 views
3 citations

Case Report

Published on 18 Jul 2022

Case Report: Invasive Fungal Infection and Daratumumab: A Case Series and Review of Literature

in Hematologic Malignancies

Francesca Farina
V. Ferla
S. Marktel
D. Clerici
S. Mastaglio
T. Perini
C. Oltolini
R. Greco
F. Aletti
A. Assanelli

Frontiers in Oncology

doi 10.3389/fonc.2022.867301

3,196 views
3 citations

Original Research

Published on 15 Jul 2022

Immune Reconstitution of Patients Who Recovered From Steroid-Refractory Acute Graft-Versus-Host Disease After Basiliximab Treatment

in Hematologic Malignancies

Dao-Xing Deng
Shuang Fan
Xiao-Hui Zhang
Lan-Ping Xu
Yu Wang
Chen-Hua Yan
Huan Chen
Yu-Hong Chen
Wei Han
Feng-Rong Wang

Frontiers in Oncology

doi 10.3389/fonc.2022.916442

2,076 views
3 citations

Original Research

Published on 15 Jul 2022

Incidence of late-onset hemorrhagic cystitis and its effect on PFS in acute leukemia patients after haplo-PBSCT: The 5-year single-center data

in Hematologic Malignancies

Hailong Yuan
Gang Chen
Jianli Xu
Ruixue Yang
Maria Muhashi
Gulibadanmu Aizezi
Ming Jiang

Frontiers in Oncology

doi 10.3389/fonc.2022.913802

2,210 views
5 citations

Brief Research Report

Published on 14 Jul 2022

Recurrent Novel P2RY8/IGH Translocations in B-Lymphoblastic Leukemia/Lymphoma

in Hematologic Malignancies

Yanglan Fang
Man Wang
Shuhong Hu
Tanzhen Wang
Yujie Liu
Jinyan Xiao
Yiming Cai
Ying Wang
Huiying Qiu
Xiaowen Tang

Frontiers in Oncology

doi 10.3389/fonc.2022.896858

2,705 views
1 citation

Case Report

Published on 14 Jul 2022

Case Report: Monoclonal Gammopathies of Clinical Significance-Associated Myopathy: A Case-Based Review

in Hematologic Malignancies

Hongbin Yu
Du He
Qing Zhang
Bei Cao
Weiping Liu
Yu Wu

Frontiers in Oncology

doi 10.3389/fonc.2022.914379

4,891 views
4 citations

Original Research

Published on 14 Jul 2022

Clear Improvement in Real-World Chronic Myeloid Leukemia Survival: A Comparison With Randomized Controlled Trials

in Hematologic Malignancies

Claudia Vener
Silvia Rossi
Pamela Minicozzi
Rafael Marcos-Gragera
Hélène A. Poirel
Marc Maynadié
Xavier Troussard
Gabriella Pravettoni
Roberta De Angelis
Milena Sant

Frontiers in Oncology

doi 10.3389/fonc.2022.892684

4,712 views
4 citations

Review

Published on 14 Jul 2022

Multiple Myeloma With Amplification of Chr1q: Therapeutic Opportunity and Challenges

in Hematologic Malignancies

Romanos Sklavenitis-Pistofidis
Gad Getz
Irene Ghobrial
Maria Papaioannou

Frontiers in Oncology

doi 10.3389/fonc.2022.961421

3,234 views
2 citations

Original Research

Published on 14 Jul 2022

Comparison of Outcomes of Haploidentical Peripheral Blood Stem Cell Transplantation Supported by Third-Party Cord Blood Versus Human Leukocyte Antigen-Matched Sibling Peripheral Blood Stem Cell Transplantation in Hematologic Malignancy Patients

in Hematologic Malignancies

Tingting Cheng
Yan Chen
Yi Liu
Xia Ma
Cong Zeng
Xu Chen
Shiyu Wang
Yajing Xu

Frontiers in Oncology

doi 10.3389/fonc.2022.922120

2,196 views
3 citations

Review

Published on 14 Jul 2022

Novel Agents For Relapsed and Refractory Classical Hodgkin Lymphoma: A Review

in Hematologic Malignancies

Yujie Zhang
Zhichao Xing
Li Mi
Zhihui Li
Jingqiang Zhu
Tao Wei
Wenshuang Wu

Frontiers in Oncology

doi 10.3389/fonc.2022.929012

7,997 views
5 citations

Review

Published on 13 Jul 2022

Single-Cell Metabolomics in Hematopoiesis and Hematological Malignancies

in Hematologic Malignancies

Fengli Zuo
Jing Yu
Xiujing He

Frontiers in Oncology

doi 10.3389/fonc.2022.931393

4,654 views
8 citations

Original Research

Published on 13 Jul 2022

Epidemiological Characteristics of Peripheral T-Cell Lymphoma: A Population-Based Study

in Hematologic Malignancies

Shuo Liu
Weiping Liu
Huichao Li
Lei Yang
Yuqin Song
Xi Zhang
Yangyang Cheng
Qingyu Li
Haoxin Li
Ning Wang

Frontiers in Oncology

doi 10.3389/fonc.2022.863269

5,780 views
5 citations

Original Research

Published on 12 Jul 2022

Impact of the Types and Relative Quantities of IGHV Gene Mutations in Predicting Prognosis of Patients With Chronic Lymphocytic Leukemia

in Hematologic Malignancies

Matthew Kaufman
Xiao-Jie Yan
Wentian Li
Emanuela M. Ghia
Anton W. Langerak
Laura Z. Rassenti
Chrysoula Belessi
Neil E. Kay
Frederic Davi
John C. Byrd

Frontiers in Oncology

doi 10.3389/fonc.2022.897280

5,883 views
2 citations

Navigation group

Articles

The Role of Clonal Evolution on Progression, Blood Parameters, and Response to Therapy in Multiple Myeloma

Survival Risk Scores for Real-Life Relapsed/Refractory Multiple Myeloma Patients Receiving Elotuzumab or Carfilzomib In Combination With Lenalidomide and Dexamethasone as Salvage Therapy: Analysis of 919 Cases Outside Clinical Trials

MRD in Venetoclax-Based Treatment for AML: Does it Really Matter?

Allogeneic haematopoietic stem cell transplantation with decitabine-containing preconditioning regimen in TP53-mutant myelodysplastic syndromes: A case study

Case Report: Invasive Fungal Infection and Daratumumab: A Case Series and Review of Literature

Immune Reconstitution of Patients Who Recovered From Steroid-Refractory Acute Graft-Versus-Host Disease After Basiliximab Treatment

Incidence of late-onset hemorrhagic cystitis and its effect on PFS in acute leukemia patients after haplo-PBSCT: The 5-year single-center data

Recurrent Novel P2RY8/IGH Translocations in B-Lymphoblastic Leukemia/Lymphoma

Case Report: Monoclonal Gammopathies of Clinical Significance-Associated Myopathy: A Case-Based Review

Clear Improvement in Real-World Chronic Myeloid Leukemia Survival: A Comparison With Randomized Controlled Trials

Multiple Myeloma With Amplification of Chr1q: Therapeutic Opportunity and Challenges

Comparison of Outcomes of Haploidentical Peripheral Blood Stem Cell Transplantation Supported by Third-Party Cord Blood Versus Human Leukocyte Antigen-Matched Sibling Peripheral Blood Stem Cell Transplantation in Hematologic Malignancy Patients

Novel Agents For Relapsed and Refractory Classical Hodgkin Lymphoma: A Review

Single-Cell Metabolomics in Hematopoiesis and Hematological Malignancies

Epidemiological Characteristics of Peripheral T-Cell Lymphoma: A Population-Based Study

Impact of the Types and Relative Quantities of IGHV Gene Mutations in Predicting Prognosis of Patients With Chronic Lymphocytic Leukemia